- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05153382
Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder (DB1)
Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder: Focus on Predictors and Mediators of Treatment Outcomes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Amanda Moss, MSW
- Phone Number: 33227 416-535-8501
- Email: amanda.moss@camh.ca
Study Contact Backup
- Name: Vanessa Rajamani, MSW
- Phone Number: 31761 416-535-8501
- Email: vanessa.rajamani@camh.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M6J 1H4
- Recruiting
- Centre for Addiction and Mental Health
-
Contact:
- Amanda Moss, MSW
- Phone Number: 33227 416-535-8501
- Email: amanda.moss@camh.ca
-
Principal Investigator:
- Benjamin I Goldstein, MD, PhD
-
Contact:
- Vanessa Rajamani, MSW
- Phone Number: 31761 416-535-8501
- Email: vanessa.rajamani@camh.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
1) English-speaking; 2) Age 13 years, 0 months to 23 years, 11 months; 3) Meet diagnostic criteria for BD by KSADS-PL (< 20 years of age) or SCID-5-RV (> 20 years of age) OR have a biological parent/sibling with BD (type I or II) confirmed via KSADS-PL or SCID-5-RV; 4) If BD-I, taking ≥1 mood stabilizing medication (i.e., antimanic anticonvulsant, antipsychotic, and/or lithium); 5) Followed by a psychiatrist who provides ongoing care; 6a) At least 1 suicide attempt in the past year (actual, interrupted, and/or aborted as measured by the C-SSRS) OR at least 1 preparatory act or behavior in the past year as measured by the C-SSRS OR non-suicidal self-injurious (NSSI) behaviors in the past 3 months (as measured by the C-SSRS) -OR- 6b) Meet youth threshold for at least 2 impulsive behavior categories on question #4 from the SIDP-IV or 1 category is identified as severe (through case discussion that will focus on level of risk, persistence, and impairment); 7) Able and willing to give informed consent/assent to participate.
Exclusion Criteria:
1) Evidence of mental retardation, moderate to severe autism spectrum disorder, or organic central nervous system disorder by the K-SADS-PL (< 20 years of age), parent report, medical history, or school records that would interfere with active participation in DBT; 2) A life-threatening medical condition requiring immediate treatment; 3) Current victim of sexual or physical abuse; 4) Current substance use disorder other than mild cannabis or alcohol use disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Youth with and/or at familial risk for bipolar disorder
60 youth aged 13 to 23 with and/or at familial risk for bipolar disorder will be enrolled in the dialectical behavioral therapy intervention.
|
DBT will be conducted over 1 year, and divided into two modalities: skills training, conducted in 60 minute biweekly meetings and individual therapy conducted in 60 minute biweekly sessions.
Family participation in skills training is highly encouraged.
Skills training proceeds as follows: psychoeducation, mindfulness skills, emotion regulation skills, distress tolerance skills, interpersonal skills, and walking the middle path skills.
Individual therapy sessions aim to aid the youth in applying skills in their daily lives.
We adopt the standard DBT hierarchy of treatment targets, whereby the individual therapist selects behaviors to focus on based on the following priorities: 1) decreasing life-threatening behaviors, 2) decreasing therapy-interfering behaviors, 3) decreasing quality-of-life interfering behaviors, and 4) increasing behavioral skills.
Therapists will be available to participants by cell phone for in-vivo skills coaching between sessions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder
Time Frame: Baseline to 6 months
|
Borderline and antisocial personality symptoms will be assessed using the Structured Interview for DSM-IV Personality.
The SID-P uses a semi structured interview format to assess for symptoms of personality disorders.
Scores one each item range from 0 to 3 and high scores indicate symptoms of borderline personality disorder and levels of impairment.
|
Baseline to 6 months
|
|
Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder
Time Frame: 6 months to 12 months
|
Borderline and antisocial personality symptoms will be assessed using the Structured Interview for DSM-IV Personality.
The SID-P uses a semi structured interview format to assess for symptoms of personality disorders.
Scores one each item range from 0 to 3 and high scores indicate symptoms of borderline personality disorder and levels of impairment.
|
6 months to 12 months
|
|
Change in symptoms using the Mood and Feelings Questionnaire (MFQ)
Time Frame: Baseline to 3 months
|
Self-reported and parent reported depressive and manic symptoms will be measured via the Mood and Feelings Questionnaire (MFQ).
Responses are made on a 3-point scale ("0=not true", "1=sometimes true" and "2=true").
|
Baseline to 3 months
|
|
Change in symptoms using the Mood and Feelings Questionnaire (MFQ)
Time Frame: 3 months to 6 months
|
Self-reported and parent reported depressive and manic symptoms will be measured via the Mood and Feelings Questionnaire (MFQ).
Responses are made on a 3-point scale ("0=not true", "1=sometimes true" and "2=true").
|
3 months to 6 months
|
|
Change in symptoms using the Mood and Feelings Questionnaire (MFQ)
Time Frame: 6 months to 9 months
|
Self-reported and parent reported depressive and manic symptoms will be measured via the Mood and Feelings Questionnaire (MFQ).
Responses are made on a 3-point scale ("0=not true", "1=sometimes true" and "2=true").
|
6 months to 9 months
|
|
Change in symptoms using the Mood and Feelings Questionnaire (MFQ)
Time Frame: 9 months to 12 months
|
Self-reported and parent reported depressive and manic symptoms will be measured via the Mood and Feelings Questionnaire (MFQ).
Responses are made on a 3-point scale ("0=not true", "1=sometimes true" and "2=true").
|
9 months to 12 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: Baseline to 3 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
Baseline to 3 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 3 months to 6 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
3 months to 6 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 6 months to 9 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
6 months to 9 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 9 months to 12 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
9 months to 12 months
|
|
Change in symptoms using the Adolescent Longitudinal Interval Follow-up Evaluation (ALIFE)
Time Frame: Baseline to 6 months
|
The Longitudinal Interval Follow-up Evaluation (LIFE) will provide a comprehensive cross-sectional and longitudinal picture of the symptomatic and psychosocial course and outcome of all participants in this study.
Scores range from 0-3 on certain disorders and 0-6 for other disorders.
High scores indicate high level of symptom impairment.
|
Baseline to 6 months
|
|
Change in symptoms using the Adolescent Longitudinal Interval Follow-up Evaluation (ALIFE)
Time Frame: 6 months to 12 months
|
The Longitudinal Interval Follow-up Evaluation (LIFE) will provide a comprehensive cross-sectional and longitudinal picture of the symptomatic and psychosocial course and outcome of all participants in this study.
Scores range from 0-3 on certain disorders and 0-6 for other disorders.
High scores indicate high level of symptom impairment.
|
6 months to 12 months
|
|
Change in suicidality using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: Baseline to 6 months
|
Suicidal events (past and over follow-up) will be assessed with the Pediatric Version of the Columbia-Suicide Severity Rating Scale (C-SSRS).
The C-SSRS has sound psychometric properties, yields ratings of widely accepted definitions of youth suicidal events, and was used in other pediatric treatment trials yielding standardized outcomes to compare across studies.
This is a semi-structured interview that includes yes/no questions as well as narrative.
It captures number of suicidal events as well as type and severity.
|
Baseline to 6 months
|
|
Change in suicidality using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 6 months to 12 months
|
Suicidal events (past and over follow-up) will be assessed with the Pediatric Version of the Columbia-Suicide Severity Rating Scale (C-SSRS).
The C-SSRS has sound psychometric properties, yields ratings of widely accepted definitions of youth suicidal events, and was used in other pediatric treatment trials yielding standardized outcomes to compare across studies.
This is a semi-structured interview that includes yes/no questions as well as narrative.
It captures number of suicidal events as well as type and severity.
|
6 months to 12 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: Baseline to 3 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
Baseline to 3 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 3 months to 6 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
3 months to 6 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 6 months to 9 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
6 months to 9 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 9 months to 12 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
9 months to 12 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 3 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
3 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 6 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
6 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 9 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
9 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 12 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
12 months
|
|
Change in affective lability using the Children's Affective Lability Scale (CALS)
Time Frame: Baseline to 3 months
|
The Children's Affective Lability Scale (CALS) is a reliable 20-item adolescent- and parent-reported measure of mood lability, derived from the adult Affective Lability Scale that was specifically designed for adults with BD.
It yields a total score as well as an angry/depressed factor and a disinhibited/impersistent factor.
Total scores can vary from 0 to 80, with lower scores indicating a lesser degree of affective lability.
|
Baseline to 3 months
|
|
Change in affective lability using the Children's Affective Lability Scale (CALS)
Time Frame: 3 months to 6 months
|
The Children's Affective Lability Scale (CALS) is a reliable 20-item adolescent- and parent-reported measure of mood lability, derived from the adult Affective Lability Scale that was specifically designed for adults with BD.
It yields a total score as well as an angry/depressed factor and a disinhibited/impersistent factor.
Total scores can vary from 0 to 80, with lower scores indicating a lesser degree of affective lability.
|
3 months to 6 months
|
|
Change in affective lability using the Children's Affective Lability Scale (CALS)
Time Frame: 6 months to 9 months
|
The Children's Affective Lability Scale (CALS) is a reliable 20-item adolescent- and parent-reported measure of mood lability, derived from the adult Affective Lability Scale that was specifically designed for adults with BD.
It yields a total score as well as an angry/depressed factor and a disinhibited/impersistent factor.
Total scores can vary from 0 to 80, with lower scores indicating a lesser degree of affective lability.
|
6 months to 9 months
|
|
Change in affective lability using the Children's Affective Lability Scale (CALS)
Time Frame: 9 months to 12 months
|
The Children's Affective Lability Scale (CALS) is a reliable 20-item adolescent- and parent-reported measure of mood lability, derived from the adult Affective Lability Scale that was specifically designed for adults with BD.
It yields a total score as well as an angry/depressed factor and a disinhibited/impersistent factor.
Total scores can vary from 0 to 80, with lower scores indicating a lesser degree of affective lability.
|
9 months to 12 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: Baseline to 3 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
Baseline to 3 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 3 months to 6 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
3 months to 6 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 6 months to 9 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
6 months to 9 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 9 months to 12 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
9 months to 12 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: Baseline to 3 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
Baseline to 3 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 3 months to 6 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
3 months to 6 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 6 months to 9 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
6 months to 9 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 9 months to 12 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
9 months to 12 months
|
|
Change in family functioning using the Family Adaptability and Cohesion Evaluation Scale, IV (FACES-IV)
Time Frame: Baseline to 3 months
|
The Family Adaptability and Cohesion Evaluation Scale (FACES-IV) was developed to evaluate the adaptability and cohesion dimensions in family interactions.
Youth and parents will complete this self-report questionnaire.
Six scales were developed, with two balanced scales and four unbalanced scales designed to tap low and high cohesion (disengaged and enmeshed) and flexibility (rigid and chaotic).
Ratio scores above 1 indicate healthier families whereas ratio scores below 1 indicate more problematic families.
The six scales in FACES-IV were found to be reliable and valid.
Additionally, high levels of concurrent, construct, and discriminant validity were found.
|
Baseline to 3 months
|
|
Change in family functioning using the Family Adaptability and Cohesion Evaluation Scale, IV (FACES-IV)
Time Frame: 3 months to 6 months
|
The Family Adaptability and Cohesion Evaluation Scale (FACES-IV) was developed to evaluate the adaptability and cohesion dimensions in family interactions.
Youth and parents will complete this self-report questionnaire.
Six scales were developed, with two balanced scales and four unbalanced scales designed to tap low and high cohesion (disengaged and enmeshed) and flexibility (rigid and chaotic).
Ratio scores above 1 indicate healthier families whereas ratio scores below 1 indicate more problematic families.
The six scales in FACES-IV were found to be reliable and valid.
Additionally, high levels of concurrent, construct, and discriminant validity were found.
|
3 months to 6 months
|
|
Change in family functioning using the Family Adaptability and Cohesion Evaluation Scale, IV (FACES-IV)
Time Frame: 6 months to 9 months
|
The Family Adaptability and Cohesion Evaluation Scale (FACES-IV) was developed to evaluate the adaptability and cohesion dimensions in family interactions.
Youth and parents will complete this self-report questionnaire.
Six scales were developed, with two balanced scales and four unbalanced scales designed to tap low and high cohesion (disengaged and enmeshed) and flexibility (rigid and chaotic).
Ratio scores above 1 indicate healthier families whereas ratio scores below 1 indicate more problematic families.
The six scales in FACES-IV were found to be reliable and valid.
Additionally, high levels of concurrent, construct, and discriminant validity were found.
|
6 months to 9 months
|
|
Change in family functioning using the Family Adaptability and Cohesion Evaluation Scale, IV (FACES-IV)
Time Frame: 9 months to 12 months
|
The Family Adaptability and Cohesion Evaluation Scale (FACES-IV) was developed to evaluate the adaptability and cohesion dimensions in family interactions.
Youth and parents will complete this self-report questionnaire.
Six scales were developed, with two balanced scales and four unbalanced scales designed to tap low and high cohesion (disengaged and enmeshed) and flexibility (rigid and chaotic).
Ratio scores above 1 indicate healthier families whereas ratio scores below 1 indicate more problematic families.
The six scales in FACES-IV were found to be reliable and valid.
Additionally, high levels of concurrent, construct, and discriminant validity were found.
|
9 months to 12 months
|
|
Number, frequency, and type of therapy sessions
Time Frame: At the end of study completion (five years)
|
The Therapy Tracking Form will be used to document the date of the therapy session, type of session, session duration, content, and scheduled date for next therapy visit.
This form will be completed by the study therapist after each therapy session.
|
At the end of study completion (five years)
|
|
Change in functioning using the Children's Global Assessment Scale (C-GAS) or Global Assessment of Functioning (GAF)
Time Frame: Baseline to 6 months
|
The Children's Global Assessment Scale (C-GAS) is an adaptation of the Global Assessment of Functioning Scale (GAF) developed to reflect the lowest level of functioning for a child or adolescent during a specified time period. Scores can range from 1-100, with scores above 70 designated as indicating normal functioning. This scale was found to be reliable between interviewers across time. Also, it has demonstrated both discriminant and concurrent validity. This will be completed for participants aged 19 and younger. The GAF is a scale originally included in the Diagnostic and Statistical Manual of Mental Disorders (DSM; 4th edition), and is used to rate adult participants' lowest and highest level of functioning in the past year, as well as their current level. It has been found to be reliable and valid. This will be completed for participants aged 20 and older. |
Baseline to 6 months
|
|
Change in functioning using the Children's Global Assessment Scale (C-GAS) or Global Assessment of Functioning (GAF)
Time Frame: 6 months to 12 months
|
The Children's Global Assessment Scale (C-GAS) is an adaptation of the Global Assessment of Functioning Scale (GAF) developed to reflect the lowest level of functioning for a child or adolescent during a specified time period. Scores can range from 1-100, with scores above 70 designated as indicating normal functioning. This scale was found to be reliable between interviewers across time. Also, it has demonstrated both discriminant and concurrent validity. This will be completed for participants aged 19 and younger. The GAF is a scale originally included in the Diagnostic and Statistical Manual of Mental Disorders (DSM; 4th edition), and is used to rate adult participants' lowest and highest level of functioning in the past year, as well as their current level. It has been found to be reliable and valid. This will be completed for participants aged 20 and older. |
6 months to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Childhood Trust Events Survey (CTES)
Time Frame: Baseline
|
Youth will complete the Childhood Trust Events Survey (CTES) long-form, adolescent version, a 30-item self-report screening survey that assesses exposure to adversity across a breadth of domains including physical, emotional, and sexual abuse; alcohol/drug users in home; family members in prison; caregiver with mental illness; domestic violence; loss/separation from caregiver; and other traumatic events.
In addition, the CTES queries the age and perceived intensity of each type of adversity.
Parents will complete the caregiver version of the CTES, a 26-item survey that asks if their child has been exposed to the same domains of adversity as queried in the adolescent version.
|
Baseline
|
|
Change in parental psychological distress using the Symptom Checklist-90 (SCL-90)
Time Frame: Baseline to 3 months
|
The Symptom Checklist-90 (SCL-90) is 90-item parent-reported measure used to assess symptoms and complaints that parents may have.
It assesses the following dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and other.
|
Baseline to 3 months
|
|
Change in parental psychological distress using the Symptom Checklist-90 (SCL-90)
Time Frame: 3 months to 6 months
|
The Symptom Checklist-90 (SCL-90) is 90-item parent-reported measure used to assess symptoms and complaints that parents may have.
It assesses the following dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and other.
|
3 months to 6 months
|
|
Change in parental psychological distress using the Symptom Checklist-90 (SCL-90)
Time Frame: 6 months to 9 months
|
The Symptom Checklist-90 (SCL-90) is 90-item parent-reported measure used to assess symptoms and complaints that parents may have.
It assesses the following dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and other.
|
6 months to 9 months
|
|
Change in parental psychological distress using the Symptom Checklist-90 (SCL-90)
Time Frame: 9 months to 12 months
|
The Symptom Checklist-90 (SCL-90) is 90-item parent-reported measure used to assess symptoms and complaints that parents may have.
It assesses the following dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and other.
|
9 months to 12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Benjamin I Goldstein, MD, PhD, Centre for Addiction and Mental Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 049/2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
Vielight Inc.Not yet recruitingBipolar Disorder (BD) | Bipolar | Bipolar Disorder DepressionCanada
-
ProgenaBiomeWithdrawnBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Xenon Pharmaceuticals Inc.RecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Xenon Pharmaceuticals Inc.Enrolling by invitationBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderUnited States
-
University of California, Los AngelesUniversity of Colorado, Denver; University of Pittsburgh; University of Cincinnati and other collaboratorsRecruitingAdolescents | Bipolar Disorder (BD) | Bipolar Disorder I or II | Bipolar Disorder NOS | Bipolar Spectrum DisorderUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
Babes-Bolyai UniversityRecruitingBipolar Disorder (BD)Romania
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Korea University Anam HospitalHucircadian; Korea University MedicineEnrolling by invitationMood Disorders | Bipolar Disorder (BD) | Depression - Major Depressive Disorder | Depression BipolarSouth Korea
Clinical Trials on Dialectical behavioral therapy
-
Bronx VA Medical CenterUnknown
-
Dartmouth-Hitchcock Medical CenterWithdrawnSurgery | FractureUnited States
-
Sunnybrook Health Sciences CentreCentre for Addiction and Mental Health; University of PittsburghCompletedBipolar DisorderCanada
-
Centre for Addiction and Mental HealthRecruiting
-
University of ManitobaCanadian Institutes of Health Research (CIHR); Diabetes CanadaRecruitingPrevention | Type2DiabetesCanada
-
Sunnybrook Health Sciences CentreUniversity of PittsburghCompleted
-
University of WindsorRecruitingDepression | Mood Disorders | Stress | Anxiety | Depression - Major Depressive DisorderCanada
-
University Hospital, Strasbourg, FranceCompletedAutism Spectrum DisordersFrance
-
Duke UniversityCompleted
-
Rutgers, The State University of New JerseyCompletedEmotional Regulation | AffectUnited States